-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core_Weighted.PDF
January 01, 2013 - W MCC 42,076 0.12%
181: RESPIRATORY NEOPLASMS W CC 43,622 0.12%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,609 0.02%
42: Secondary malignancies 200,515 0.56%
43: Malignant … neoplasm without specification of site 9,147 0.03%
44: Neoplasms of unspecified nature or uncertain … behavior 42,887 0.12%
45: Maintenance chemotherapy; radiotherapy 158,964 0.45%
46: Benign neoplasm … of uterus 113,052 0.32%
47: Other and unspecified benign neoplasm 132,169 0.37%
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2.PDF
January 01, 2012 - W MCC 17,087 0.13%
181: RESPIRATORY NEOPLASMS W CC 19,272 0.14%
182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 10,069 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … ; other and unspecified primary 2,917 0.02%
42: Secondary malignancies 83,841 0.62%
43: Malignant neoplasm … 18,475 0.14%
45: Maintenance chemotherapy; radiotherapy 60,731 0.45%
46: Benign neoplasm of uterus … 57,767 0.43%
47: Other and unspecified benign neoplasm 57,065 0.42%
48: Thyroid disorders 16,796 0.12%
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2_Weighted.PDF
January 01, 2012 - W MCC 42,405 0.12%
181: RESPIRATORY NEOPLASMS W CC 47,403 0.13%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,786 0.02%
42: Secondary malignancies 206,465 0.57%
43: Malignant … neoplasm without specification of site 9,218 0.03%
44: Neoplasms of unspecified nature or uncertain … behavior 45,048 0.12%
45: Maintenance chemotherapy; radiotherapy 157,338 0.43%
46: Benign neoplasm … of uterus 127,128 0.35%
47: Other and unspecified benign neoplasm 138,602 0.38%
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core_Weighted.PDF
January 01, 2014 - W MCC 42,501 0.12%
181: RESPIRATORY NEOPLASMS W CC 40,684 0.12%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,459 0.02%
42: Secondary malignancies 195,142 0.55%
43: Malignant … neoplasm without specification of site 8,787 0.02%
44: Neoplasms of unspecified nature or uncertain … behavior 41,860 0.12%
45: Maintenance chemotherapy; radiotherapy 154,010 0.44%
46: Benign neoplasm … of uterus 110,864 0.31%
47: Other and unspecified benign neoplasm 128,294 0.36%
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core_Weighted.PDF
January 01, 2018 - W MCC 45,550 0.13%
181: RESPIRATORY NEOPLASMS W CC 27,640 0.08%
182: RESPIRATORY NEOPLASMS W/O CC/ … W MCC 30,670 0.09%
375: DIGESTIVE MALIGNANCY W CC 37,805 0.11%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 22,410 0.06%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … PROC EXC MALIGNANCY W/O CC/MCC 1,275 0.00%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 2,005 0.01% … : MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 8,890 0.03%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
January 01, 2019 - W MCC 46,920 0.13%
181: RESPIRATORY NEOPLASMS W CC 26,375 0.07%
182: RESPIRATORY NEOPLASMS W/O CC/ … W MCC 32,470 0.09%
375: DIGESTIVE MALIGNANCY W CC 37,710 0.11%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 22,945 0.06%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … PROC EXC MALIGNANCY W/O CC/MCC 2,235 0.01%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 1,910 0.01% … : MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 8,290 0.02%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_Core.PDF
January 01, 2018 - W MCC 9,110 0.13%
181: RESPIRATORY NEOPLASMS W CC 5,528 0.08%
182: RESPIRATORY NEOPLASMS W/O CC/MCC … W MCC 6,134 0.09%
375: DIGESTIVE MALIGNANCY W CC 7,561 0.11%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … OF PANCREAS EXCEPT MALIGNANCY W MCC 10,278 0.14%
439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC … PROCEDURES FOR NEOPLASM W/O CC/MCC 4,482 0.06%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … PROC EXC MALIGNANCY W/O CC/MCC 255 0.00%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 401 0.01%
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core_Weighted.PDF
January 01, 2013 - W MCC 42,965 0.12%
181: RESPIRATORY NEOPLASMS W CC 43,265 0.12%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,230 0.02%
42: Secondary malignancies 195,925 0.55%
43: Malignant … neoplasm without specification of site 8,950 0.03%
44: Neoplasms of unspecified nature or uncertain … behavior 42,635 0.12%
45: Maintenance chemotherapy; radiotherapy 157,135 0.44%
46: Benign neoplasm … of uterus 104,565 0.29%
47: Other and unspecified benign neoplasm 126,435 0.36%
48: Thyroid disorders
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-1996
January 01, 1996 - FOBT can also miss small adenomas and colorectal malignancies that bleed intermittently or not at all … Distribution of colorectal neoplasms. A left-to-right shift of polyps and cancer. … Screening for colon malignancy with colonoscopy. … Large colonoscopic neoplasms missed by endoscopy. … The incidence of benign and malignant neoplasms of the colon and rectum: a postmortem study.
-
hcup-us.ahrq.gov/reports/methods/2011_04.pdf
January 01, 2011 - PROCEDURES FOR NON-NEOPLASM
W CC
661 18538 1.0365 1.0586 0.9791
KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … ; other and unspecified primary
42 141831 1.48567 1.56413 0.94984 Secondary malignancies
43 84445 … 1.18135 1.19507 0.98852 Malignant neoplasm without specification of site
44 30659 1.42852 1.5136 0.94379 … chemotherapy; radiotherapy
46 112890 0.73898 0.7662 0.96448 Benign neoplasm of uterus
47 99604 1.38732 … 1.42113 0.97621 Other and unspecified benign neoplasm
48 29271 0.74777 0.76243 0.98076 Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
January 01, 2019 - W MCC 46,641 0.13%
181: RESPIRATORY NEOPLASMS W CC 26,830 0.08%
182: RESPIRATORY NEOPLASMS W/O CC/ … W MCC 31,054 0.09%
375: DIGESTIVE MALIGNANCY W CC 36,694 0.10%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 23,168 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … 723: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W CC 3,713 0.01%
724: MALIGNANCY, MALE REPRODUCTIVE SYSTEM … : MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 8,260 0.02%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
January 01, 2018 - W MCC 16,522 0.09%
375: DIGESTIVE MALIGNANCY W CC 21,174 0.12%
376: DIGESTIVE MALIGNANCY W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 12,577 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … PROC EXC MALIGNANCY
W/O CC/MCC
711 0.00%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC 1,141 0.01% … 723: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W CC 2,300 0.01%
724: MALIGNANCY, MALE REPRODUCTIVE SYSTEM … MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM W CC 4,912 0.03%
756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
May 01, 2012 - analysis included all Medicare ben-
eficiaries with claims indicating a diagno-
sis in the malignant or benign … neoplasms
range of the ICD-9 codes (140-239) and
receipt of proton beam therapy (HCPCS
77520-77525 … cancers (Table 7). … Typically a prostate cancer case will have this daily
charge 30 times, and ocular tumor 5 times. … fur-
ther multiplied by the fact that with 6 to 8 weeks of therapy (compared
to one week for ocular neoplasms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - For example,
the literature for the use of HSCT in the hematologic malignancies is relatively robust … long-term effects (e.g., growth and development, cognitive
ability, future fertility, and secondary malignancies … Malignant Solid Tumors (Key Questions 1 and 2)
P: Pediatric patients with malignant solid tumors including … "[Mesh] OR (wilm* AND (tumor OR tumors OR
tumour*))
10:49:05 11596
#32 Search "therapeutic use … Search #72 NOT #5 11:24:57 3127
#72 Search (#70 AND #49) AND #32 11:20:04 3295
#70 Search ("Neoplasms
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
January 01, 2019 - W MCC 131 0.00%
181: RESPIRATORY NEOPLASMS W CC 183 0.00%
182: RESPIRATORY NEOPLASMS W/O CC/MCC <= … W MCC <= 50 *.**%
375: DIGESTIVE MALIGNANCY W CC 79 0.00%
376: DIGESTIVE MALIGNANCY W/O CC/MCC <= … OF PANCREAS EXCEPT MALIGNANCY W MCC 1,097 0.02%
439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC 2,711 … FOR NEOPLASM W/O CC/MCC 197 0.00%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 483 0.01% … PROC EXC MALIGNANCY W/O CC/MCC <= 50 *.**%
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM W MCC <= 50 *.*
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
September 26, 2023 - Background
Although anal cancer only represents1-2 percent of all gastrointestinal malignancies,
incidence … iliac nodes), M0
III T3-T4 (tumor >5cm in greatest dimension or tumor of any size invading … A., & American Joint Committee on Cancer Expert Panel on Cancers of the
Lower Gastrointestinal, Anus … ti,ab. 28776
22
10 Neoplasm grading/ or Neoplasm Invasiveness/ or Neoplasm Metastasis/ or … Neoplasm Recurrence, Local/ or Recurrence/ or neoplasm staging/ or Tumor Burden/ or
((neoplasm?
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
January 01, 2019 - W MCC 97 0.00%
181: RESPIRATORY NEOPLASMS W CC 135 0.00%
182: RESPIRATORY NEOPLASMS W/O CC/MCC 29 … W MCC 37 0.00%
375: DIGESTIVE MALIGNANCY W CC 59 0.00%
376: DIGESTIVE MALIGNANCY W/O CC/MCC 18 0.00% … OF PANCREAS EXCEPT MALIGNANCY W MCC 811 0.03%
439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY W CC 2,006 … FOR NEOPLASM W/O CC/MCC 146 0.00%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 354 0.01% … W MCC 34 0.00%
687: KIDNEY & URINARY TRACT NEOPLASMS W CC 82 0.00%
688: KIDNEY & URINARY TRACT NEOPLASMS
-
hcup-us.ahrq.gov/db/nation/nrd/Supp-AnalysisICD10Readmissions.xlsx
January 01, 2017 - -4.50 Stable 1,745 11.11 1,612 10.75 -3.27 Stable * * * * * *
658: KIDNEY & URETER PROCEDURES FOR NEOPLASM … Unstable 1,486 26.24 2,265 25.99 -0.96 Stable * * * * * *
660: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … PROC EXC MALIGNANCY W/O CC/MCC * * * * * * * * * * * * * * * *
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM … 10.01 29,428 9.96 -0.53 Stable
17: MYELOPROLIFERATIVE DISEASES & DISORDERS, POORLY DIFFERENTIATED NEOPLASM … PROC EXC MALIGNANCY W/O CC/MCC * * * * * * * * * * * * * * * *
722: MALIGNANCY, MALE REPRODUCTIVE SYSTEM
-
hcup-us.ahrq.gov/toolssoftware/chronic_icd10/CCIR-User-Guide-v2025-1.pdf
November 01, 2024 - For example, diagnoses indicating pregnancy, or a benign neoplasm are not chronic
conditions, but also … considered chronic except basal cell carcinomas, benign neoplasms (except benign
neoplasms of the brain … uncertain behavior (except benign neoplasms of the brain, cranial nerves, and
cerebral/spinal meninges … Codes indicating a pre-existing chronic condition (e.g., hypertension, diabetes
mellitus, malignant … neoplasm) complicating pregnancy, childbirth, or the puerperium are chronic.
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_IP_MaskedStats.PDF
January 01, 2019 - W MCC 9,103 0.19
181: RESPIRATORY NEOPLASMS W CC 4,667 0.10
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 79 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 3,385 0.07 … W MCC 762 0.02
687: KIDNEY & URINARY TRACT NEOPLASMS W CC 1,137 0.02
688: KIDNEY & URINARY TRACT NEOPLASMS … W MCC 9,106 0.19
181: RESPIRATORY NEOPLASMS W CC 4,666 0.10
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 79 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 3,389 0.07